Walden Group Healthcare M&A Blog

  • Boston Scientific to Acquire Devoro Medical, Inc. for $320m

    Boston Scientific Corporation (NYSE: BSX; “BSX“), a $10b producer of interventional technologies for general surgery, neurosurgery, and cardiovascular health has announced the acquisition of Devoro Medical, a developer of a blood clot retrieval and removal system for arterial and venous systems.  BSX has been a minority investor in Devoro...
    Read More
  • Stryker Acquires AI Blood Monitoring Company Gauss Surgical

    Stryker Corporation, a $14.4b medical technology company focused on orthopedics, neurotechnology and spine, acquired Gauss Surgical, a developer of artificial intelligence-enabled technology for real-time monitoring of blood loss during surgery. Gauss Surgical’s Triton system leverages a computer vision app and iPhone to measure a patient’s...
    Read More
  • Abbott Acquires Walk Vascular

    Abbott Laboratories (NYSE: ABT), a $35b global producer of diagnostics, devices, generic pharmaceuticals and nutritional products, has acquired Walk Vascular, LLC, a developer of a commercialized thrombectomy system used to remove peripheral blood clots (JETi system). The JETi system works by inserting a distal catheter into veins and arteries...
    Read More
  • Medtronic to Acquire Intersect ENT

    Medtronic plc (Nasdaq: MDT), a $30.1b Ireland-based producer of devices used in cardiovascular, neuroscience, surgical, and diabetes management applications, is acquiring Intersect ENT (Nasdaq: XENT), a developer of an ENT implant that releases steroids during sinus surgery to manage inflammation and a virtual surgical guidance platform.  In...
    Read More
  • The Walden Group Releases Q2 2021 Strategic Healthcare M&A Report

    The Walden Group is pleased to provide access to its Q2 2021 Strategic Healthcare M&A Report, which includes:     Financings (IPOs, SPACs, private) and M&A Deals are surging     Major M&A Deals by Sector     What the CEOs of Leading Medtechs are Saying     Key Stats on Top Healthcare M&A Q2 Deals     Key Stats on...
    Read More